AJANTA PHARMA LTD. - USFDA inspection for Paithan plant
09 Feb 2017
Ajanta Pharma Ltd has informed BSE that the Company's Paithan facility was recently inspected by US FDA and the Company has issued one procedural related 483. The Company is in process of responding to the same within the stipulated time prescribed by US FDA.
Source:
BSE India